Jason Grenfell-Gardner is the founder of The J. Molner
Company. He is an experienced pharmaceutical industry expert and has worked at
the forefront of drug development in the United States and Canada. At Teligent
Inc., he and his team submitted more than 50 drug approval applications and
launched over 40 medicines. Jason has served on the boards of several
companies, most recently as a board member of Pfenex, Inc., a San Diego-based
biotechnology company.
Jason is a passionate advocate of corporate social
responsibility. Patients, access to healthcare and diversity in the workplace
are particularly important to him.
“We
have built a strong foundation in Estonia and are now scaling internationally.
I am looking for an operational leader who is ready to take ownership and build
the next stage of J. Molner together with us.”
Jason
Grenfell-Gardner, Founder & CEO